Hypothesis the pruritus of cholestasis: From bile acids to opiate agonists

Hepatology

Volumn 11, Issue 5, 1990, Pages 884-887

  Jones, E Anthony ^a   Bergasa, Nora V ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; OPIATE AGONIST; ENDORPHIN; OPIATE RECEPTOR;

ARTICLE; CHOLELITHIASIS; HUMAN; PRIORITY JOURNAL; PRURITUS; ANIMAL; BIOLOGICAL MODEL; CHOLESTASIS; CHRONIC DISEASE; FORECASTING; LIVER DISEASE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ANIMAL; BILE ACIDS AND SALTS; CHOLESTASIS; CHRONIC DISEASE; ENDORPHINS; FORECASTING; HUMAN; LIVER DISEASES; MODELS, BIOLOGICAL; PRURITUS; RECEPTORS, OPIOID;

EID: 0025426954     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.1840110526     Document Type: Article

References (68)

1. Cholestasis.
2. Liver transplantation: an overview
3. Bile acids on the skin of patients with pruritic hepatobiliary disease
4. Bile acids and bile acid sulfates in the skin of patients with cholestasis and pruritus
5. Pruritus induced by crude bile and purified bile acids: experimental production of pruritus in human skin
6. Pruritic effect of bile salts
7. The neurohistology and neurophysiology of the itch sensation in man
8. Pruritus in cholestasis: no direct causative role for bile acid retention
9. Itch in liver disease: facts and speculation
10. Elevations in skin tissue levels of bile acids in human cholestasis: relation to serum levels and to pruritus
11. Bile acid profiles of human serum and skin interstitial fluid and their relationship to pruritus studied by gas chromatography‐mass spectrometry
12. Pruritus of cholestasis is related to effects of bile salts on the liver, not the skin
13. Safety and efficacy of longterm treatment of familial intrahepatic cholestasis with phenobarbital
14. Serum bile acids in primary biliary cirrhosis
15. Lowering of serum bile acid concentrations and relief of pruritus in jaundiced patients fed a bile acid sequestering resin
16. Relief of the pruritus of jaundice with a bile sequestering resin
17. Treatment of pruritus and hypercholesterolemia of primary biliary cirrhosis with cholestyramine
18. Cholestyramine for long term relief of the pruritus complicating intrahepatic cholestasis
19. Drugs used in the treatment of hyperlipoproteinemias.
20. Cholestyramine
21. Effect of cholestyramine on bile acid metabolism in normal man
22. Cholestyramine in uraemic pruritus
23. Relief of intractable pruritus in polycythaemia rubra vera with cholestyramine
24. Phenobarbital effects in cholestatic liver disease
25. Treatment of pruritus of cholestasis by plasma perfusion through USP‐charcoal‐coated glass beads
26. Phototherapy for pruritus in chronic cholestasis of childhood
27. The relief of pruritus in primary biliary cirrhosis by hydroxythylrutosides
28. Treatment of pruritus due to chronic obstructive liver disease
29. Treatment of pruritus in primary biliary cirrhosis with rifampin: results of a double‐blind, crossover randomized trial
30. Effect of stanozolol on itching in primary biliary cirrhosis
31. Partial external diversion of bile for the treatment of intractable pruritus associated with intrahepatic cholestasis
32. Side effects of epidural morphine
33. Intrathecal and epidural administration of opioids
34. Opioid analgesics and antagonists.
35. Itching after epidural and spinal opiates
36. The price of intraspinal narcotic analgesia: basic constraints
37. Butorphanol‐induced pruritus antagonized by naloxone
38. Spinal opiate analgesia and facial pruritus: a neural theory
39. Intraspinal opiates and itching: a new reflex:
40. Continuous thoracic epidural fentanyl: a comparison of epidural fentanyl with intramuscular papaveretum for postoperative pain
41. Epidural and intrathecal opiates for postoperative pain relief
42. Epidural fentanyl in the management of postoperative pain
43. Experimental study of itch stimuli in animals
44. Relief of intractable pruritus with naloxone
45. Spinal opiate analgesia: characteristics and principles of action
46. Serum levels following epidural administration of morphine and correlation with relief of postsurgical pain
47. Nonrespiratory side effects of epidural morphine
48. Skin diseases.
49. Morphine tolerance in hepatic cirrhosis
50. Nalmefene: intravenous safety and kinetics of a new opioid antagonist
51. Opioid peptides and primary biliary cirrhosis
52. Prolonged blockade of opioid effect with oral nalmefence
53. Clonidine blocks acute opiate‐withdrawal symptoms
54. Clonidine for opiate detoxification: outpatient clinical trials
55. The combined use of clonidine and naltrexone as a rapid, safe and effective treatment of abrupt withdrawal from methadone
56. Naloxoneprecipitated withdrawal: a method for rapid induction onto naltrexone
57. Studies of the opiate control of prolactin, GH and TSH
58. Is ascites caused by impaired hepatic inactivation of blood‐borne endogenous opioid peptides?
59. Plasma methionine enkephalin concentration and prognosis in primary biliary cirrhosis
60. Blood‐brain barrier, half‐time disappearance and brain distribution for labelled enkephalin and a potent analog
61. Entry of opioid peptides into the central nervous system
62. Carrier‐mediated transport of enkephalins and N‐tyr‐MIF ‐1 across blood‐brain barrier
63. Transport of leucine‐enkephalin across the blood‐brain barrier in the perfused guinea pig brain
64. Naloxone modulates the perception of itch in man
65. Opiates, sleep and itch
66. A new method for the measurement of itch and the response to treatment
67. The measurement of itch with sensitive limb movement meters
68. Objective quantitation of pruritus in patients with cholestatic liver disease [Abstract]